Research on Material Basis of Homologous and Heterogeneous Effect of Aurantii Fructus Immaturus and Aurantii Fructus Based on Total Statistical Moment Analysis and Molecular Connectivity Index / 中国实验方剂学杂志

ObjectiveTo investigate the material basis of homologous and heterogeneous effect of Aurantii Fructus Immaturus（AFI） and Aurantii Fructus（AF） based on the total statistical moment analysis and molecular connectivity index（MCI）. MethodRelevant literature at home and abroad and Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform（TCMSP） were consulted to establish the chemical composition database of AFI and AF， and set up their fingerprints by ultra-high performance liquid chromatography（UPLC）， and the total statistical moments and similarity parameters of the fingerprint were calculated. According to MCI， all components of AFI and AF were divided into different component groups， the average values of 0-8th order（0χ-8χ） MCI of the common component groups of AFI and AF were calculated. ResultThe values of total zero-order moment（AUCT） of AFI and AF were （10.57±2.45）×106， （5.09±0.89）×106 μV·s， the values of total first-order moment（MCRTT） were （11.57±1.58）， （12.10±1.29） min， the values of total second-order moments（VCRTT） were（24.49±2.30）， （26.49±2.54） min2， respectively. It showed that qualitative and quantitative parameters of AFI and AF were significantly different. The components with high similarity such as neohesperidin， hesperidin and narirutin were screened as the common potential pharmacodynamic components of AFI and AF. The non-common components of AFI， such as alysifolinone and imperatorin， and the non-common components of AF， such as neoeriocitrin and isosakuranin， with high similarity were screened out as potential heterogeneous components of AFI and AF. The composition groups of AFI and AF were classified into six categories， and the similarities between the composition groups of AFI and AF and the total constituents were 0.872-0.979 and 0.918-0.997， the average values of 0χ-8χ MCI of alkaloids in AFI and AF were 3.65 and 3.14， the average values of 0χ-8χ MCI of flavonoids were 8.47 and 8.47， the average values of 0χ-8χ MCI of volatile oils were 2.71 and 3.48， respectively. It showed that there were some differences in MCI of chemical constituents（groups） between AFI and AF. ConclusionThe chemical constituents（groups） of AFI and AF not only differ in content and species， but also in structural characteristics and structure-activity relationship， which can provide a basis for further explaining the scientific connotation of homologous and heterogeneous effect of AFI and AF.

Undergraduate Medical Students’ Experience with Foundation Course at a Public Medical College in India

The study aimed to explore the perception and knowledge-gainof undergraduate medical students during the Medical Council ofIndia-mandated one month foundation course in August, 2019. Atotal of 129 consenting students who underwent the foundationcourse were enrolled and their feedback collected using anemail-based structured questionnaire. A majority (>60%) hadpositive attitudes towards various aspects of the course, withgood scores obtained in the post-test by the majority of thestudents. The information reported will assist in the planning offuture foundation course programs

Bioinformatics analysis of miRNAs in mild cognitive impairment due to Alzheimer's disease / 上海交通大学学报（医学版）

Objective: To analyze the expression profile of plasma microRNA (miRNA) in patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD) by bioinformatics method, and explore its pathogenesis at the level of genetic regulation. Methods: Five MCI patients due to AD and five control participants were recruited. The plasma miRNA expression profiles were analyzed by miRNA microarray sequencing. Target genes of significantly up-regulated miRNAs were detected by TargetScan 7.2 database. The miRNA-gene interaction network of significantly up-regulated miRNAs was established by Cytoscape software, and the key miRNAs of the network were analyzed. The target genes of key miRNAs were analyzed by Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway analysis using R packages. Results: There are 13 up-regulated miRNAs in the plasma of MCI patients due to AD, and 5 of them were key miRNAs in miRNA-gene interaction network. Target genes of these miRNAs were mainly involved in biological process such as synaptic plasticity reg-ulation, Wnt signaling pathway, synaptic vesicle transport and synaptic vesicle localization, as well as Ras signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway and glycolysis/gluconeogenesis pathway. Conclusion: Five up-regulated miRNAs in plasma of MCI due to AD may be the main regulators involved in the pathological mechanism of AD, which can be used as potential biomarkers for diagnosis of MCI due to AD.

Preliminary evaluation of common experimental animal models for Alzheimer' s disease and mild cognitive impairment / 中国药理学通报

Alzheimer∗ s disease (AD) is a typical central nervous degenerative disease characterized by progressive cognitive impairment and behavioral damage, which is associated with the major pathological manifestations of extracellular amyloid deposition, intracellular neurofibrillary tangles, and neuron loss. Mild cognitive impairment ( MCI) is a kind of cognitive impairment status between normal cognition and AD, which is linked with a high risk of converting into AD. Previous studies mostly establish the animal models with clinical AD characteristics for mechanism research, drug screening, and new drug development. In recent years, researchers have attempted to establish animal models with clinical MCI characteristics, trying to intervene ear-ly at MCI stage to effectively prevent the occurrence of AD. There are many types of AD experimental animal models, and the MCI model should be distinguished from the AD model. Based on the systematic introduction of the characteristics of AD and MCI, this study aims to preliminarily evaluate the commonly used AD and MCI experimental animal models, providing sug-gestions for the research of AD and MCI.

Yet another Experiment in Medical Education

The problem of searcity of doctors for providing services to the nation is a matter of great concerned Recently T.O.I. 21-04-2019 documented that Government desired a bridge course for dental surgeon to practice the family medicine to overcome the shortage of serving doctors for the society. Recently we have also noticed a great change in MCI and the new establishment wants a great change in curriculum and syllabus and another system of learning process have been introduced in medical education. Medical colleges have been directed to switch over the new system of learning curriculum in UG. I do not know what motive conquered their concept of mind to reach at this new course model? How do they feel to bring a drastic change in medical education system, knowing that nothing have changed in civic perception of medical benefit at mass T.O.I. 09-06-2019 published an article “How Medical education became a business, one policy change at a time, more to lift fee cap one more step towards commercialization, say activists.” This requires further sensitization of the medical field. It is morbid attempt.

Studies on Alzheimer Disease - Metformin Connection - A Brief Review

Metformin is the widely prescribed first line oral antidiabetic drug used in diabetes mellatus, type 2 . The global sales turnover of metformin runs into millions of dollars. The Increased risk of metformin (Met) users for developing Alzheimer disease (AD)is reported first in a study conducted in 2011. Since then, the subject has attracted the attention of the researchers as well as the pharmaceutical industry, resulting in a number of studies, both clinical as well as experiments on animals. Confusing results poured in , ranging from confirmation of the risk of AD to protection against developing AD , making the scenario, all the more intriguing . Added to the confusion, is the diversity of various studies as well as the parameters interpreting their results. Of the many clinical trials, some are retrospective cohort studies(Tseng Chin-Hsiao 2019) , case controlstudies (Imfeld P, et al.) Randomised studies (Hsu CC, et al.),double blind , cross over pilot studies. (Aaron Koenig et al.)and some longitudinal studies (Ng TP, et al.) , besides studies doing meta analysis .Of these studies most of the trials estimate the risk of development of dementia withmetformin alone (Tseng Chin-Hsiao 2019) or in comparison with other OHAs (Hsu et al,Chenget al.) .The other studies studied the effect of metformin on the cognition. (Moore EM, et al.).These trials have different out come measures, (like Hazard ratio, (HR) Odds(OR) ratio, relative risk (RR) etc.)which don’t mean one and the same. So the multiplicity of the types of studies and different out-comes with different conclusions will be surely baffling to an average reader who tries to take cognisance of the involved issues. The article attempts to take stock of the overall developments in this regard. The author adopted a reader friendly approach which is discussed in the article, at the outset. Finally, it is reiterated that future prospective studies only can resolve the conflict of opinion on the nexus between metformin and Alzheimer’s disease

Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson's disease / Valores de corte da versão em português do "montreal cognitive assessment" para avaliação cognitiva na doença de parkinson

ABSTRACT. The Movement Disorder Society has published some recommendations for dementia diagnosis in Parkinson disease (PD), proposing the Montreal Cognitive Assessment (MOCA) as a cognitive screening tool in these patients. However, few studies have been conducted assessing the Portuguese version of this test in Brazil (MOCA-BR). Objective: the aim of the present study was to define the cut-off points of the MOCA-BR scale for diagnosing Mild Cognitive Impairment (PD-MCI) and Dementia (PD-D) in patients with PD. Methods: this was a cross-sectional, analytic field study based on a quantitative approach. Patients were selected after a consecutive assessment by a neurologist, after an extensive cognitive evaluation, and were classified as having normal cognition (PD-N), PD-MCI or PD-D. The MOCA-BR was then applied and 89 patients selected. Results: on the cognitive assessment, 30.3% were PD-N, 41.6% PD-MCI and 28.1% PD-D. The cut-off score on the MOCA-Br to distinguish PD-N from PD-D was 22.50 (95% CI 0.748-0.943) for sensitivity of 85.5% and specificity of 71.1%. The cut-off for distinguishing PD-D from MCI was 17.50 (95% CI 0.758-0.951) for sensitivity of 81.6% and specificity of 76%.

RESUMO. A Movement Disorder Society publicou algumas recomendações para o diagnóstico de demência na doença de Parkinson (DP), propondo o Montreal Cognitive Assessment (MOCA) como ferramenta de triagem cognitiva nesses pacientes. Entretanto, poucos estudos foram aplicados à versão em português (MOCA-BR). Objetivo: o presente estudo tem o objetivo de definir os valores de corte na escala de MOCA-BR para diagnosticar o Comprometimento Cognitivo Leve (DP-CCL) e Demência (DP-D) em pacientes com DP. Métodos: trata-se de um estudo transversal, analítico, com uma abordagem quantitativa. Os pacientes foram selecionados depois de avaliações consecutivas por um neurologista, após avaliação cognitiva extensa, e foram classificados como cognição normal (DP-N), DP-CCL e DP-D e então o MOCA-BR foi aplicado, sendo selecionados 89 pacientes. Resultados: na avaliação cognitiva, foram encontrados 30.3% de DP-N, 41.6% de DP-CCL e 28.1% DP-D. O valor de corte no MOCA-BR para distinguir entre DP-N de DP-D foi 22.5 (IC 95%; 0.748-0.943), sensibilidade de 85.5% e especificidade de 71.1%. Para distinguir DP-P de CCL, o ponto de corte foi de 17.5 (IC 95%; 0.758-0.951), sensibilidade de 81.6% e especificidade de 76%.

Parkinson′s disease with cognitive impairment / 中国实用内科杂志

Parkinson's disease(PD) is a progressive neurodegenerative disease characterized by motor symptoms such as rigidity, rest tremor, and bradykinesia. However, evidence demonstrated that PD encompasses several non-motor disturbances as well, such as cognitive impairment. Mild cognitive impairment can be present since early stages of the disease, and characterized by impairments in several cognitive domains including executive functions, attention, and visuospatial skills, language, and memory; In advanced stages of the disease, cognitive defects can develop into dementia and there is a considerable heterogeneity in the cognitive impairments. In this review, we focus on the clinical characteristics, biomarkers, and drug and non-drug treatments of cognitive impairment in Parkinson's disease, hoping to provide help for clinical practice.

Java Ginger Bangle / 日本補完代替医療学会誌

The review reveals latest studies of Bangle that has unique ingredients, safety, healthy effect and especially neurotrophin activity. Banglenes have some neurotrophin activity such as neuritogenesis without NGF in vitro, property that enhances hippocampal neurogenesis and crosses the blood-brain barrier (BBB) in vivo. On the other hand, Java ginger bangle (Extract) improves spatial learning in Senescence-Accelerated Mouse. Moreover the human clinical trial for MCI (Mild Cognitive Impairment) have been just started.

Deterioro Conductual Leve (MBI), Deterioro Cognitivo Leve (MCI) y desarrollo de la demencia: implicancias diagnósticas y clínicas / Mild Behavioral Impairment (MBI), Mild Cognitive Impairment (MCI) and development of dementia: diagnostic and clinical implications

Tanto el Deterioro Conductual Leve (MBI) y el Deterioro Cognitivo Leve (MCI) han sido identificados como estados o fases predemenciales. Estas entidades constituyen factores de riesgo para el desarrollo de las demencias y en muchos casos, una manifestación temprana de las mismas. En este contexto, los síntomas neuropsiquiátricos que caracterizan al MBI no solo podrían presentarse concurrentemente con el MCI, sino también antes de su aparición o incluso sin que este se llegara a presentar. Esta aparición selectiva del MBI sigue representando un gran desafío en términos de la comprensión de su etiología y el sustrato neurobiológico que podría compartir con el MCI. En este artículo se presentan las características centrales del MBI, los criterios que se emplean para su diagnóstico, las relaciones que guarda con el MCI y sus posibles biomarcadores, para discutir algunos aspectos relacionados con su diagnóstico clínico

Study of a screening system for mild cognitive impairment based on machine learning model / 上海交通大学学报（医学版）

Objective:To evaluate the reliability and validity of a computerized cognitive assessment system designed for screening mild cognitive impairment (MCI), and compare the screening accuracy among constructed different machine learning classification models. Methods:A group of random stratified samples of over 55 years old residents in the communities, nursing homes and memory-clinics from Shanghai and Henan were selected to assess their cognitive status using Montreal Cognitive Assessment (MoCA) by well-trained investigators. The reliability and validity were assessed by intrinsic consistency analysis and factor analysis, respectively. Taking the results of MoCA as standards, four machine learning classification algorithms, i.e., naïve Bayesian classification model, random forest classifier, Logistic regression classifier, and K-nearest neighbor classifier, were compared in accuracy and area under curve (AUC). Results:A total of 359 participants were included, the median age of whom was 63 years old. And 82.80% of them were secondary school graduates or below. According to the results of MoCA, 147 of them might be MCI. The Cronbach's α and KMO of this system were 0.84 and 0.78, respectively; Bartlett's sphericity test was significant (P<0.05); thirteen common factors could explain 75.10% of the system. The best classification model was naïve Bayesian classification model, and its accuracy and AUC were 88.05% and 0.941, respectively. Conclusion:The new designed computerized cognitive assessment system has been proved to be reliable and valid. The naïve Bayesian classification model has good classification accuracy.

Comparación de la respuesta inicial luego de la ablación con 30 mCi de 131I versus no ablación en pacientes con cáncer diferenciado de tiroides de bajo riesgo de recurrencia. Estudio prospectivo multicéntrico / Comparison of initial response to treatment after remnant ablation (RA) with 30 mCi of 131 I versus no RA in patients with differentiated thyroid cancer with low risk of recurrence. Multicentric prospective study

RESUMEN Material y métodos Estudio prospectivo multicéntrico. Se incluyeron 174 pacientes con CDT tratados consecutivamente desde junio 2014 hasta mayo 2015. Se los dividió en 2 grupos (ablacionados y no ablacionados) con 87 pacientes incluidos en cada uno. La respuesta inicial al tratamiento se determinó con la medición de tiroglobulina, anticuerpos anti-tiroglobulina y ecografía de cuello. Resultados Se compararon las características basales de ambos grupos y no se evidenciaron diferencias estadísticamente significativas: sexo femenino 84% y 88% (p = 0,5); edad promedio de 46,8 y 47,5 años (p = 0,7); carcinoma papilar variedad clásico 68% y 75,9% (p = 0,15), respectivamente. El resto de las características basales como tamaño tumoral, bilateralidad, multifocalidad, tiroiditis de Hashimoto y estadio tumoral tampoco mostraron diferencias significativas. La evaluación de la respuesta inicial al tratamiento se realizó en 64 pacientes del grupo ablacionado y en 76 del grupo no ablacionado. Se observó una respuesta excelente en 81% de pacientes ablacionados vs. 87% del grupo no ablacionado, con una frecuencia de respuesta estructural incompleta de 1,6% y 1,4%, respectivamente, (p = 0,9). Un 17% de los ablacionados y 12% de los no ablacionados presentaron una respuesta indeterminada. Conclusión: Los pacientes de bajo riesgo, ablacionados o no, presentan similares frecuencias de respuesta inicial excelente y estructural incompleta. El seguimiento a largo plazo podrá definir si estas respuestas iniciales se mantienen en el tiempo, lo que permitirá reducir la indicación de ablación con radioyodo en este grupo de pacientes con CDT.

ABSTRACT Patients and methods We included 174 patients; 87 patients in each group (ablated and nonablated). Assessment of the initial response to treatment was performed by measurement of thyroglobulin and anti-thyroglobulin antibodies and by neck ultrasonography. Results Baseline characteristics of both groups were compared, and no statistically significant differences were found: female sex 84% and 88,5%, respectively, (p = 0.5); mean age of 46.8 and 47.5 years, respectively (p = 0.7); papillary carcinoma classic variant 68% and 75.9%, respectively (p = 0.15). The remaining of the baseline characteristics such as tumor size, presence of bilaterality, multifocality, Hashimoto's thyroiditis and tumor stage were not statistically significant, either. The evaluation of the response to treatment was finally performed in 64 patients from the ablated group and in 76 from the non-ablated group. An excellent response to treatment was observed in 81% of ablated patients vs. 87% of the non-ablated group, with a frequency of structural incomplete response of 1.6% and 1.4%, respectively (p = 0.9). On the other hand, 17% and 12% of patients in each group had an indeterminate response. Conclusion Low-risk ablated and non-ablated patients have a similar frequency of excellent initial and structural incomplete response to treatment. Long-term follow-up is needed to establish whether these initial responses are maintained over time, and thus further refine the indications of RA in this group of patients with DTC.

Characteristic of brain microbleeds in Alzheimer's disease / 上海交通大学学报（医学版）

Objective: To evaluate the differences of brain microbleeds among Alzheimer's disease (AD), amnesia mild cognitive impairment (aMCI) and normal control (NC). Methods: Eighteen AD patients, 28 aMCI patients and 30 age-matched NC were recruited in the study. The location and number of microbleeds was recorded in the brain according to the susceptibility-weighted images. The bilateral frontal lobe, parietal lobe, occipital lobe, temporal lobe, and thalamus were manually mapped on 3D-MR imaging. The number of cases with microbleeds and the number of microbleeds in each lobe were calculated and compared among three groups using the chi-square test and ANOVA. Results: Significant differences on case number with microbleeds were found between AD group and NC group in the frontal lobe (P=0.005), the temporal lobe (P=0.005) and whole brain (P=0.004), and between aMCI group and NC group in the frontal lobe (P=0.048). It also showed significant differences among three groups in the frontal lobe (P=0.006), the temporal lobe (P=0.006) and whole brain (P=0.016). For the microbleeds counts, significant differences were found between AD group and NC group in the frontal lobe (P=0.004) and the temporal lobe (P=0.049), and between AD group and NC group in the frontal lobe (P=0.044). It also had significant differences among three groups in the frontal lobe (P=0.016), the temporal lobe (P=0.038) and whole brain (P=0.048). Conclusion: The AD group has more significant microbleeds in frontal and parietal lobes in comparison to NC group. The quantization of cerebral microbleeds may be a potential biomarker for AD diagnosis.

Pattern Visual Evoked Potential (VEP) is Unaffected in the Early Stage of Mild Cognitive Impairment / Jurnal Sains Kesihatan Malaysia

The aim of this study was to determine whether pattern-reversal Visual Evoked Potential (PRVEP) is affected in mild cognitive impairment (MCI). Participants aged ≥ 60 years diagnosed as MCI were invited to participate in a study together with a group of controls. PRVEP was measured using A RETI-port/Scan 21 and stimuli of large and small checks sizes, 1° (60 min of arc) and 0.25° (15 min) respectively were used to obtain responses. The amplitude and implicit times of the MCI and control groups were then compared. A total of 18 MCI participants (age 65.7 ± 3.1 years) and 18 controls (65.1 ± 3.8 years) consented to participate in the study. The amplitude and implicit times for the MCI group using the target sizes of 60 min of arc were 9.80 ± 4.06 μV and 108.83 ± 7.63 ms and for 30 min of arc were 11.00 ± 7.44 μV and 123.96 ± 6.18 ms respectively. Consecutively for the control groups the amplitudes and implicit times were 8.96 ± 3.52μV, 105.85 ± 3.60 ms and 11.97± 6.11 μV, 122.57 ± 8.28 ms. PRVEP results did not reveal significant differences in P100-wave amplitude nor implicit time between the two groups under investigation. This study concluded that the visual pathway of MCI participants may be unaffected in the early part of the disease process.

Evolución de la categorización semántica en adultos mayores con diagnóstico de DCL-A y DTA y sin patología neurológica / Evolution of semantic categorization in older adults with and without neurological disease

Tradicionalmente la memoria semántica ha sido definida como un tesoro mental que almacena información sobre las palabras, su significado, como así también la relación entre ellas, los hechos y los conceptos. Una de las vías principales para explicar cómo se organiza la información en la memoria semántica (MS) es a través de categorías. La demencia tipo Alzheimer (DTA) suele estar caracterizada por un deterioro en la memoria episódica. Sin embargo, se debate en torno al deterioro de la misma, en qué momento aparece, a qué se debe y si hay una pérdida diferencial en distintos momentos de la enfermedad. El objetivo del trabajo que se informa fue analizar los procesos de categorización semántica en adultos mayores sanos comparándolos con dos grupos de personas con patologías neurológicas: uno con diagnóstico de deterioro cognitivo leve (DCL) y otro con demencia tipo Alzheimer (DTA), emparejados por edad, nivel educativo y género. Para ello, se utilizaron tareas tradicionales para evaluar la memoria semántica y también un método novedoso, el DISTSEM, que permite evaluar las estimaciones que realizan las personas de las distancias semánticas entre los conceptos. Los resultados mostraron que el grupo de personas sin patología tuvo un rendimiento superior en todas las tareas en comparación con los grupos de personas con patología neurológica. Por otro lado, el grupo con DTA mostró un deterioro semántico afectando en primer lugar a la categoría seres vivos. El DCL preservó la estructura categorial sólo con pequeñas intrusiones. El DISTSEM mostró ser un instrumento adecuado para la discriminación entre sujetos sanos y DTA.

Traditionally, semantic memory has been defined as a mental trove that contains organized information about words and their meaning, as well as relationships between words, facts and concepts.There are different ways of explaining how the information in such memory system is represented and organized. One of the main ways of explaining this organization is through categories. Categorization starts the very moment that any sensorial perception is associated to an abstract category; it is the ability to organize information in equivalence classes, and it is very important because it allows us to summarize the information that we gather through our senses and thus facilitate its manipulation. Alzheimer's disease (AD) is the main cause of dementia among older adults, and it is one of the most pressing sanitary, social and cultural problems of the present times. The main risk factor for the illness is age, for its prevalence augments exponentially from 65 to 85 years old, and due to the rise in life expectancy it is considered that it might be transformed into a world-wide epidemic in the coming years. The start of the illness is insidious and slowly progressing, and it is characterized by a loss of episodic memory from its beginnings. With respect to the deterioration of semantic memory in AD, a debate has arisen about its mode of presentation, its causes, and whether there is a differential loss of categories (live or non-live beings) in different moments of the illness. During the 90s, Petersen proposed the concept of mild cognitive impairment (MCI) to label the subjects with a functional cognitive impairment insufficient to diagnose a dementia syndrome. The importance of this syndrome is that between 8 to 15% of those who suffer it evolve to AD annually, while in the general population this evolution is only from 1 to 2%. However, there is a great controversy about the validity and scope of the term MCI, for its etiology can be very varied and it is very difficult to predict its evolution. There are different sub-kinds of MCI, and the amnesic form is the more likely to evolve into AD, for its main characteristic is the subjective deterioration of memory corroborated by standardized test by reference to normative data for the same age and educational level of the subject. The other cognitive functions not present alterations. The main objective of this work was to analyze the semantic categorization processes in healthy older adults comparing them with two groups of people with neurological pathologies, one with diagnosis of MCI and the other with AD, matched by age, educational level and gender. To evaluate this categorization process, two traditional tasks were used together with a novel method, the DISTSEM, which allows the evaluation of the estimation made by people about the semantic distance among a set of given concepts. The results showed that the group of people without pathologies had a superior performance in all the tasks in comparison with the groups of people with neurological pathologies. On the other hand, the group with AD showed a semantic impairment which affected in the first place the category of live beings, which was evident in the all the tasks. The MCI preserved the categorical structure with only minor intrusions. The DISTSEM has shown itself to be a valuable instrument that allows the discrimination between healthy subjects and those with AD. It is expected that this work can provide empirical evidence relevant to the debate surrounding semantic memory, for studies in patients with brain injury offer key information to examine the organizing models of such memory.

Doença de Alzheimer prodrômica. MCI, biomarcadores, prevenção e novas drogas / Alzheimer´s disease prodromal AD, mild cognitive impairment, prevention and new drugs

Este artigo discute dois novos conceitos: doença de Alzheimer prodrômica (DAp) e deficiência cognitiva leve / mild cognitive impairment (MCI). Aborda a questão dos biomarcadores e da perspectiva futura de tratamentos e prevenção.

Techniques and strategies for characterization and isolation 01 chemical components of traditional chinese medicines / 国际药学研究杂志

The chemical composition of traditional Chinese medicine (TCM) is the material base for its prevention and treatment of disease. Characterization, analysis and isolation of chemical constituents, important fields of modern research on TCM, however, are still a great challenge due to the complexity. In recent years, considerable progress has been made in these fields with the application of new chromatographic packing materials and methods, analysis technologies represented by LC-MS and the associated databases and softwares. Here, the advancement of methods and strategies used in the research on the chemical constituents of TCM is briefly reviewed.

Techniques and strategies for characterization and isolation of chemical components of traditional Chinese medicines / 国际药学研究杂志

The chemic al composition of traditional Chinese medicine (TCM) is the material base for its prevention and treatment of disease. Characterization, analysis and isolation of chemical constituents, important fields of modern research on TCM, however, are still a great challenge due to the complexity. In recent years, considerable progress has been made in these fields with the application of new chromatographic packing materials and methods, analysis technologies represented by LC-MS and the associated databases and softwares. Here, the advancement of methods and strategies used in the research on the chemical constituents of TCM is briefly reviewed.

Puntuaciones del MoCA y el MMSE en pacientes con deterioro cognitivo leve y demencia en una clínica de memoria en Bogotá / MoCA and MMSE scores in patients with mild cognitive impairment and dementia in a memory clinic in Bogotá

Introducción. Diferentes pruebas neuropsicológicas permiten explorar las funciones cognitivas del adulto mayor, en un tiempo corto. En Colombia se dispone de pocos estudios sobre puntuaciones y puntos de corte para el MMSE y para el MoCA en relación al diagnóstico de deterioro cognitivo. Objetivo. Describir la distribución de las puntuaciones del MMSE y el MoCA y los puntos de corte con mejor discriminación, para el diagnóstico de deterioro cognitivo leve y demencia, en una muestra de pacientes de Bogotá. Material y métodos. Se evaluaron 248 pacientes por un equipo multidisciplinario, que consultaron a la Clínica de Memoria del HIUSJ entre 2009-2012, siguiendo un protocolo establecido. Se identificaron las puntuaciones del MoCA y MMSE, que permitieron obtener el mayor porcentaje de pacientes correctamente clasificados. Resultados. En el 70% de los pacientes con DCL y en el 69 % de los sujetos normales, se encontraron puntuaciones del MMSE inferiores o iguales a 28. En 91% de pacientes con DCL y 84% de los sujetos normales, se presentaron puntuaciones del MoCA inferiores o iguales a 25. Los pacientes con cualquier tipo de demencia, presentaron puntuaciones del MMSE inferiores o iguales a 27 e inferiores o iguales a 24 en el MoCA. Conclusión. Según el presente estudio, el tamizaje de funciones cognitivas, utilizando el MoCA, clasifica de manera más acertada que el MMSE, a los sujetos con deterioro cognitivo. Creemos que en atención primaria, estos puntos de corte del MoCA, pueden ser considerados por ahora, cuando se trate especialmente de sujetos con alta escolaridad.

Introduction. Some cognitive tests allow the evaluation of cognitive functions on the elderly in a short period of time. There are few studies in Colombia about cut-off point for the MMSE and the MoCA test. Objectives. To describe the distribution on scores on MMSE and MoCA test and the cut-off point with a better discrimination criteria for the diagnosis of mild cognitive impairment and dementia, in a sample of patients from Bogotá. Materials and methods. Two hundred forty eight patients were included in this study, being evaluated by a multidisciplinary team that followed an established protocol, on patients who attended to the Memory Clinic of HIUSJ between 2009-2012. MoCA test and MMSE scores that allow higher percentages of correctly classified patients were identified. Results. Seventy percent of patients with mild cognitive impairment and 69% of normal individuals had scores on MMSE below or equal to 28. Ninety-one percent of patients with MCI and 89% of normal patients, had scores below or equal to 25. Patients with any type of dementia had scores on MMSE below or equal to 27 and below or equal to 24 in MoCA test. Conclusion. According to the study, the screening of cognitive functions, using MoCA test, is more accurate than MMSE in patients with cognitive decline. The cut-off points, identified in our study, can be considered useful until now in primary attention, in patients with a high level of education.

Meta analysis on the levels of total Tau protein and β-amyloid42 in cerebrospinal fluid in mild cognitive impairment patients / 中国神经精神疾病杂志

Objective To evaluate the changes of the level of cerebrospinal fluid T-tau protein andβ-amyloid 42 in mild cognitive impairment (MCI) patients. Methods Computer retrieval was preformed for cerebrospinal fluid (CSF) to-tal tau protein (T-tau) and β-amyloid 42 (Aβ 42) levels among MCI and healthy people in Pubmed, Cochrane Library, Ovid, CNKI, VIP Data and Wangfang Data. Meta-analyses were conducted on the T-tau and Aβ42 levels using Review Manager 5.2 software. Results Seventeen studies met inclusion criteria. Meta-analysis results showed that, CSF T-tau protein levels were significantly higher (MD:113.10;95%CI:87.93-138.26) and Aβ42 levels were significantly lower in the patients with MCI, (MD=-146.50;95%CI=-178.70- -114.29) compared with the control group (P<0.01). Conclu-sions T-tau significantly increases while Aβ42 significantly decreases in the CSF in patients with MCI.